Reassessing the hemostatic disorder associated with acute promyelocytic leukemia [see comments]
Authors:
- Martin TallmanMTMartin Tallman
- Hc KwaanHKHc Kwaan
Open Access
- 1 February 1992
- journal article
- Published by American Society of Hematology in Blood
- Vol. 79 (3) , 543-553
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)New England Journal of Medicine, 1991
- Tissue Factor Released from Leukemic CellsThrombosis and Haemostasis, 1991
- Potential role of interleukin-1 as the trigger for diffuse intravascular coagulation in acute nonlymphoblastic leukemiaThe American Journal of Medicine, 1988
- Isolation and characterization of a urokinase-type plasminogen activator (Mr = 54,000) from cultured human endothelial cells indistinguishable from urinary urokinase.Journal of Biological Chemistry, 1984
- Anticoagulant Properties of Purified X-Like Fragments of Human Fibrinogen Produced by Degradation with Leukocyte ElastaseThrombosis and Haemostasis, 1984
- Changes in Plasma Levels of Protease and Fibrinolytic Inhibitors Induced by Treatment in Acute Myeloid LeukemiaThrombosis and Haemostasis, 1984
- Purification and partial characterization of A D-like fragment from human fibrinogen, produced by human leukocyte elastaseBiochimica et Biophysica Acta (BBA) - General Subjects, 1983
- Anticoagulant and calcium-binding properties of high molecular weight derivatives of human fibrinogen (plasmin fragments Y)Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1982
- Pathologic cells as procoagulant substance of disseminated intravascular coagulation syndrome in acute promyelocytic leukemiaThrombosis Research, 1976
- Coagulation Defects in Acute Promyelocytic LeukemiaArchives of internal medicine (1960), 1969